PR Newswire PharmaOriginal article
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
PartnershipPositive
AI Analysis
Summary
Genprex selected a leading CDMO partner to accelerate manufacturing scale-up for its diabetes gene therapy program, supporting IND-enabling preclinical studies and future clinical trials.
Importance:5/10
Sentiment:
0.60
gene therapymanufacturingdiabetesCDMOIND-enabling studies
Related Companies
Read the original article
Published by PR Newswire Pharma on August 18, 2026 11:00 AM
